Indogulf Cropsciences Submits Q3 FY26 Earnings Call Transcript with Growth Insights
Indogulf Cropsciences filed its Q3 FY26 earnings conference call transcript with stock exchanges, revealing strong financial performance with 17% quarterly revenue growth and strategic expansion into new international markets including Venezuela, Taiwan, and Sudan.

*this image is generated using AI for illustrative purposes only.
Indogulf Cropsciences Limited has submitted the transcript of its Q3 FY26 earnings conference call held on February 12, 2026, to BSE and NSE under Regulation 30 and 46(2)(oa) of SEBI Listing Regulations. The comprehensive transcript provides detailed insights into the company's strong financial performance and strategic initiatives during the quarter.
Regulatory Submission Details
The company submitted the earnings call transcript on February 17, 2026, through Company Secretary Sakshi Jain. The document was filed under the applicable provisions of SEBI Listing Regulations and has been uploaded on the company's website at www.groupindogulf.com .
| Submission Details: | Information |
|---|---|
| Call Date: | February 12, 2026 |
| Submission Date: | February 17, 2026 |
| BSE Scrip Code: | 544432 |
| NSE Symbol: | IGCL |
| Regulation: | 30 and 46(2)(oa) |
Q3 FY26 Financial Performance
During the earnings call, Managing Director Sanjay Aggarwal highlighted the company's resilient performance with 17% year-on-year revenue growth despite challenging market conditions including subdued crop prices and cautious farmer sentiment.
| Financial Metric: | Q3 FY26 | Q3 FY25 | Growth (%) |
|---|---|---|---|
| Revenue (₹ Million): | 1,161.00 | 992.10 | +17.0% |
| EBITDA (₹ Million): | 117.10 | 100.60 | +16.4% |
| PBT (₹ Million): | 73.80 | 46.10 | +60.2% |
| PAT (₹ Million): | 38.60 | 36.60 | +5.6% |
Nine-Month Performance Highlights
For the nine-month period ending December 31, 2025, the company demonstrated robust growth momentum across all key financial parameters, with CFO Manoj Gupta emphasizing the benefits of operating leverage and improved product mix.
| 9M Performance: | 9M FY26 | 9M FY25 | Growth (%) |
|---|---|---|---|
| Revenue (₹ Million): | 5,538.20 | 4,641.90 | +19.3% |
| EBITDA (₹ Million): | 536.40 | 434.40 | +23.5% |
| PBT (₹ Million): | 391.40 | 293.80 | +33.2% |
| PAT (₹ Million): | 284.20 | 216.80 | +31.1% |
Strategic Business Developments
The earnings call revealed significant strategic progress including successful entry into new international markets. The company received initial orders from Venezuela, Taiwan, and Sudan worth ₹4-5 crores, expected to be executed in Q4 FY26. Export order margins range from 7% to 18%.
| Business Segment Growth (9M FY26): | Growth Rate |
|---|---|
| Biologicals: | +15% |
| Plant Nutrition: | +23% |
| Crop Protection: | +14% |
| B2C Business: | +16% |
| B2B Business: | +26% |
Management Outlook and Future Plans
During the call, management expressed optimism about Q4 FY26 performance and outlined expansion plans for subsidiary AGPL into central India. The new manufacturing facility at Barwasni, delayed by 2-3 months due to GRAP conditions in Delhi NCR, is now expected to be operational by end of Q1 FY27. The company plans to launch 4-5 new products in Q1 of the upcoming fiscal year, continuing its strategy of portfolio diversification across crop protection, plant nutrients, and biologicals.
Historical Stock Returns for Indogulf Cropsciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.21% | -3.20% | -5.06% | -41.84% | -42.75% | -42.75% |


































